FDA Approves First Treatment for Patients with Fatty Liver Disease
The US Food & Drug Administration (FDA) recently approved the Edwards EVOQUE Tricuspid Valve Replacement System – P230013.
Posted in:
fatty liver disease 2 FDA 2
